Archive · 10 Jan 2026
Walmart to replace AstraZeneca on Nasdaq-100
Walmart is going to take AstraZeneca's place in the Nasdaq-100 Index.
This is a big group of the 100 most valuable companies that aren't banks and are listed on the Nasdaq.
Walmart is moving from the New York Stock Exchange to Nasdaq because they think it's a better fit for them.
Companies sometimes switch where they're listed to save money or to be with other companies that are similar to them.
The change will happen on January 20.
Walmart will replace AstraZeneca in the Nasdaq-100 Index on January 20.
Walmart is moving its listing from the New York Stock Exchange to Nasdaq.
Companies often change listing venues for better alignment with investor base, technology, and services.
The Nasdaq-100 Index includes 100 of the most valuable non-financial companies listed on Nasdaq.
Some companies cited the attractiveness of the Nasdaq-100 index as a key reason for transferring from NYSE to Nasdaq.
- Who
- Walmart and AstraZeneca
- What
- Walmart replacing AstraZeneca on Nasdaq-100 Index
- When
- January 20
- Where
- Nasdaq Stock Market
- Why
- Better alignment with investor base, technology, and services
- Company Replacing
- AstraZeneca
- Company Joining
- Walmart
- Index
- Nasdaq-100
- Effective Date
- January 20
- Reason for Change
- Better alignment with investor base, technology, and services
